The clinical relevance of luteal phase progesterone support in true natural cycle cryopreserved blastocyst stage embryo transfers: a retrospective cohort study.

Ian N Waldman, Catherine Racowsky, Emily R Disler, Ann Thomas, Andrea Lanes, Mark D Hornstein
{"title":"The clinical relevance of luteal phase progesterone support in true natural cycle cryopreserved blastocyst stage embryo transfers: a retrospective cohort study.","authors":"Ian N Waldman,&nbsp;Catherine Racowsky,&nbsp;Emily R Disler,&nbsp;Ann Thomas,&nbsp;Andrea Lanes,&nbsp;Mark D Hornstein","doi":"10.1186/s40738-021-00096-5","DOIUrl":null,"url":null,"abstract":"<p><strong>Background: </strong>More than 67% of all embryos transferred in the United States involve frozen-thawed embryos. Progesterone supplementation is necessary in medicated cycles to luteinize the endometrium and prepare it for implantation, but little data is available to show if this is beneficial in true natural cycles. We evaluated the use of luteal phase progesterone supplementation for cryopreserved/warmed blastocyst transfers in true natural cycles not using an ovulatory trigger.</p><p><strong>Methods: </strong>Retrospective cohort study in a single academic medical center. We studied the use of luteal phase progesterone supplementation in patients undergoing true natural cycle cryopreserved blastocyst embryo transfers. Our primary outcome measure was ongoing pregnancy rate, with other pregnancy outcomes being evaluated (i.e. implantation rate, miscarriage rate, ectopic rate, and multifetal gestation). Categorical data were analyzed utilizing Fisher's exact test and all binary variables were analyzed using log-binomial regression to produce a risk ratio.</p><p><strong>Results: </strong>Two hundred twenty-nine patients were included in the analysis with 149 receiving luteal phase progesterone supplementation and 80 receiving no luteal phase support. Patient demographic and cycle characteristics, and embryo quality were similar between the two groups. No difference was seen in ongoing pregnancy rate (49.0% vs. 47.5%, p = 0.8738), clinical pregnancy rate (50.3% vs. 47.5%, p = 0.7483), positive HCG rate (62.4% vs. 57.5%, p = 0.5965), miscarriage/abortion rate (5.4% vs. 2.5%, p = 0.2622), ectopic pregnancy rate (0% vs. 1.3%, p = 0.3493), or multifetal gestations (7.4% vs. 3.8%, p = 0.3166).</p><p><strong>Conclusion(s): </strong>The addition of luteal phase progesterone support in true natural cycle cryopreserved blastocyst embryo transfers did not improve pregnancy outcomes and therefore the routine use in practice cannot be recommended based on this study, but the utilization should not be discouraged without further studies.</p><p><strong>Capsule: </strong>Progesterone supplementation as luteal phase support in true natural cycle cryopreserved blastocyst transfers does not improve ongoing pregnancies.</p>","PeriodicalId":87254,"journal":{"name":"Fertility research and practice","volume":"7 1","pages":"4"},"PeriodicalIF":0.0000,"publicationDate":"2021-02-09","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7871584/pdf/","citationCount":"3","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Fertility research and practice","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.1186/s40738-021-00096-5","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"","JCRName":"","Score":null,"Total":0}
引用次数: 3

Abstract

Background: More than 67% of all embryos transferred in the United States involve frozen-thawed embryos. Progesterone supplementation is necessary in medicated cycles to luteinize the endometrium and prepare it for implantation, but little data is available to show if this is beneficial in true natural cycles. We evaluated the use of luteal phase progesterone supplementation for cryopreserved/warmed blastocyst transfers in true natural cycles not using an ovulatory trigger.

Methods: Retrospective cohort study in a single academic medical center. We studied the use of luteal phase progesterone supplementation in patients undergoing true natural cycle cryopreserved blastocyst embryo transfers. Our primary outcome measure was ongoing pregnancy rate, with other pregnancy outcomes being evaluated (i.e. implantation rate, miscarriage rate, ectopic rate, and multifetal gestation). Categorical data were analyzed utilizing Fisher's exact test and all binary variables were analyzed using log-binomial regression to produce a risk ratio.

Results: Two hundred twenty-nine patients were included in the analysis with 149 receiving luteal phase progesterone supplementation and 80 receiving no luteal phase support. Patient demographic and cycle characteristics, and embryo quality were similar between the two groups. No difference was seen in ongoing pregnancy rate (49.0% vs. 47.5%, p = 0.8738), clinical pregnancy rate (50.3% vs. 47.5%, p = 0.7483), positive HCG rate (62.4% vs. 57.5%, p = 0.5965), miscarriage/abortion rate (5.4% vs. 2.5%, p = 0.2622), ectopic pregnancy rate (0% vs. 1.3%, p = 0.3493), or multifetal gestations (7.4% vs. 3.8%, p = 0.3166).

Conclusion(s): The addition of luteal phase progesterone support in true natural cycle cryopreserved blastocyst embryo transfers did not improve pregnancy outcomes and therefore the routine use in practice cannot be recommended based on this study, but the utilization should not be discouraged without further studies.

Capsule: Progesterone supplementation as luteal phase support in true natural cycle cryopreserved blastocyst transfers does not improve ongoing pregnancies.

黄体期黄体酮支持在真正自然周期冷冻囊胚期胚胎移植中的临床意义:一项回顾性队列研究。
背景:在美国,超过67%的胚胎移植涉及冻融胚胎。在药物周期中补充黄体酮是必要的,以使子宫内膜黄体化并为着床做准备,但很少有数据表明这在真正的自然周期中是否有益。我们评估了在真正的自然周期中,在不使用排卵触发器的情况下,补充黄体期黄体酮用于冷冻保存/加热囊胚移植。方法:在单一学术医疗中心进行回顾性队列研究。我们研究了黄体期黄体酮补充在接受真正自然周期冷冻囊胚移植的患者中的应用。我们的主要结局指标是持续妊娠率,同时评估其他妊娠结局(即着床率、流产率、异位率和多胎妊娠)。分类数据采用Fisher精确检验进行分析,所有二元变量采用对数二项回归进行分析,得出风险比。结果:229例患者纳入分析,其中149例接受黄体期黄体酮补充,80例未接受黄体期黄体酮支持。两组患者人口统计学、周期特征和胚胎质量相似。持续妊娠率(49.0%比47.5%,p = 0.8738)、临床妊娠率(50.3%比47.5%,p = 0.7483)、HCG阳性率(62.4%比57.5%,p = 0.5965)、流产/流产率(5.4%比2.5%,p = 0.2622)、异位妊娠率(0%比1.3%,p = 0.3493)、多胎妊娠(7.4%比3.8%,p = 0.3166)均无差异。在真正的自然周期冷冻囊胚移植中添加黄体期黄体酮支持并没有改善妊娠结局,因此根据本研究不能推荐在实践中常规使用,但不应在没有进一步研究的情况下劝阻使用。胶囊:黄体酮补充作为黄体期支持在真正的自然周期冷冻保存囊胚移植不能改善正在进行的妊娠。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
求助全文
约1分钟内获得全文 求助全文
来源期刊
自引率
0.00%
发文量
0
审稿时长
8 weeks
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
确定
请完成安全验证×
copy
已复制链接
快去分享给好友吧!
我知道了
右上角分享
点击右上角分享
0
联系我们:info@booksci.cn Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术官方微信